Source: Eur Respir J 2007; 30: 403-406
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O'Byrne P. M.. How much is too much? The treatment of mild asthma. Eur Respir J 2007; 30: 403-406

Member's Comments

No comment yet.

Related content which might interest you: Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Treatment of severe childhood asthma: what’s the evidence? Source: Annual Congress 2005 - Difficult asthma in children Year: 2005 Can control of severe asthma be achieved? Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 Are a degree of asthma therapy related to asthma control impairment? Source: Eur Respir J 2003; 22: Suppl. 45, 370s Year: 2003 What is ‘mild asthma’, and how common is it? Source: International Congress 2018 – The complexities of managing mild asthma Year: 2018 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma Source: Eur Respir J 2003; 22: 397-398 Year: 2003 The management of mild asthma Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020 Year: 2021 Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Managing severe asthma: do we need to do more? Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives Year: 2007 Are current treatment protocols adequate for children with mild intermittent asthma? Source: Eur Respir J 2005; 26: Suppl. 49, 397s Year: 2005 Is mild asthma outside the guidelines? Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019 Is it more than just asthma? Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Omalizumab is effective in patients with severe persistent allergic asthma in a real-life setting irrespective of age Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Is quality of life impairment in asthma comparable to chronic urticaria? Source: Eur Respir J 2007; 30: Suppl. 51, 627s Year: 2007 Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018